The National Institutes of Health hosted a meeting earlier this month as leaders in Alzheimer’s and other diseases met in Bethesda, Maryland, for the AD Research Summit 2015. The first such meeting since the National Plan to Address Alzheimer’s Disease was put into action in 2012, the summit served to spur the field on toward the goal of preventing and effectively treating Alzheimer’s by 2025. Over the two-day meeting, researchers proposed ways of finding therapeutic targets outside of the familiar Aβ and tau fields. Data sharing was a big theme for this goal. Speakers also weighed in on how to enlarge patient cohorts, capture better phenotypic data, engage minority communities, and harness citizen science to analyze vast quantities of data.
At the first NIH summit since the National Plan to Address Alzheimer’s was implemented back in 2012, scientists discussed progress made and put forth a new set of goals.
At an NIH conference in Washington, D.C., experts from beyond Alzheimer’s research discussed ways to beef up data collection and patient participation.
A revised plan of action for AD research has emerged from the Alzheimer’s Disease Research Summit 2015.